CloneID: 7D12
Buffer Composition: PBS with 0.02% Proclin 300.
Chimeric Use Statement: This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.
Available Custom Conjugation Options: AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7
Uniprot Accession No.: P00533
Specificity Statement: This antibody is specific for the ligand binding site on domain III of the extracellular domain of human EGFR, overlapping with the epitope of cetuximab.
Application Notes (Clone): The binding of the original version of this antibody (VHH) to EGFR was characterized in an SPR (KD 0.012 nM), ELISA, (EC50 of 71.0 nM), and FACS (EC50 of 0.79 nM). In its bi-specific construction with Ab04388 (Anti-CEACAM5 [NbCEA5]), it served a functional role (US20220242958).